Telaleaf and Little Green Pharma Sponsor Second Session of Medical Cannabis Certificate Course for Physicians in Germany

Berlin, Germany March 28, 2022 –(PR.com)– Telaleaf Health Inc. (“Telaleaf” or the “Company”), a telemedicine company transforming the delivery of cannabis care to patients, is pleased to announce its joint sponsorship with the world’s leading medical cannabis company Little Green Pharma Ltd. (or “LGP”), the second certificate course for physicians, pharmacists and related professionals interested in the therapeutic application of cannabis-based medicines.

The course entitled “The AZ of cannabis-based therapy: Basics and practice use of cannabis-based drugs in medical practice and pharmacy” is organized by Dresden International University and launched its inaugural session September 30, 2021. The course is developed and taught by world renowned medical cannabis experts Dr. Franjo Grotenhermen, Dr. Kirsten Muller-Vahl and dr. Denis Stracke – deliver 82 lessons over a period of 12 weeks. The second session of this advanced course has begun March 24, 2022.

The course is a comprehensive, practice-oriented and interdisciplinary certificate course for physicians, providing in-depth knowledge of all aspects of cannabis therapy, which physicians and pharmacists need for appropriate and responsible therapeutic use. of all cannabis-based medicines currently available for prescription. At the end of the course, advanced training points are awarded by the Saxon State Medical Association for those with the appropriate professional affiliation.

The lecturers’ many years of individual and combined clinical, practical and scientific experience are of immense value to course participants, as well as their excellent knowledge of emerging cannabis laws and the current political and legal landscape in Germany, Europe and beyond.

“In response to popular demand from physicians for attendance at this course, we are pleased to announce that there will be 2 more courses this year. The next course is scheduled to begin in Fall 2022 and the next course is scheduled to begin in December 2022,” said Eva Alloucheco-founder and COO of Telaleaf.

For more information and to register for future courses, visit: telaleaf.com/doctors.

About Telaleaf
Telaleaf is a telemedicine company transforming the delivery of cannabis care by connecting patients to expert physicians, trained in cannabis-based medicine, who conduct virtual medical visits and provide personalized treatment plans. Our goal is to improve patient outcomes, enhancing the patient experience with high quality treatment, ease of access and expert-led training for physicians, for the most advanced virtual care in cannabis medicine.

On Small green pharmacy
Small green pharmacy is one of the world’s leading medicinal cannabis companies with key manufacturing assets in Australia and Europe. Our goal is to improve patient access to GMP-grade cannabis-based medicines worldwide and transform lives for the better. To achieve this, we prioritize assisting physicians with ongoing education on the benefits of treatment and with the prescribing process to make it as easy as possible.

Contact information:
TelafeuilleAlbert Wardi Jr..
1-647-498-0306
Contact by email
www.telaleaf.com

Read the full story here: https://www.pr.com/press-release/857952

Press release distributed by PR.com

Copyright © 2022 PR.com and its licensors, source US press releases